Exact Sciences Corporation [EXAS] stock for 46,366 USD was sold by Baranick Brian

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Exact Sciences Corporation shares valued at $46,366 were sold by Baranick Brian on Aug 05. At $47.12 per share, Baranick Brian sold 984 shares. The insider’s holdings dropped to 4,596 shares worth approximately $0.17 million following the completion of this transaction.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Also, Zanotti Katherine S sold 4,608 shares, netting a total of over 208,005 in proceeds. Following the sale of shares at $45.14 each, the insider now holds 60,318 shares.

Before that, Conroy Kevin T had sold 7 shares from its account. In a trade valued at $285, the President and CEO traded Exact Sciences Corporation shares for $40.75 each. Upon closing the transaction, the insider’s holdings decreased to 7 shares, worth approximately $42.4 million.

As published in their initiating research note from Credit Suisse on August 25, 2022, Exact Sciences Corporation [EXAS] has been an Outperform and the price target has been revised to $55. This represents a 34.0% premium over Wednesday’s closing price. Analysts at Piper Sandler started covering the stock with ‘”a Neutral”‘ outlook in a report released in early June. As of November 03, 2021, Raymond James has decreased its “Strong buy” rating to a “an Outperform” for EXAS. Earlier on July 29, 2021, Stifel resumed its rating. Their recommendation was “a Buy” for EXAS stock.

Analyzing EXAS’s Price Performance

On Wednesday, Exact Sciences Corporation [NASDAQ: EXAS] plunged -4.20% to $36.30. The stock’s lowest price that day was $36.28, but it reached a high of $38.41 in the same session. During the last five days, there has been a drop of approximately -10.50%. Over the course of the year, Exact Sciences Corporation shares have dropped approximately -53.36%. Shares of the company reached a 52-week high of $84.46 on 01/18/22 and a 52-week low of $34.16 on 09/01/22. A 50-day SMA is recorded $41.87, while a 200-day SMA reached $58.76. Nevertheless, trading volume fell to 1.62 million shares from 1.33 million shares the previous day.

Support And Resistance Levels for Exact Sciences Corporation (EXAS)

According to the 24-hour chart, there is a support level at 35.58, which, if violated, would cause prices to drop to 34.87. In the upper region, resistance lies at 37.71. The next price resistance is at 39.13. RSI (Relative Strength Index) is 40.20 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.01, which suggests the price will decrease in the coming days. Percent R is at 73.47%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Exact Sciences Corporation subject to short interest?

Stocks of Exact Sciences Corporation saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.2 million shares to 10.74 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 10.94 million shares. A decline of -1.86% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5 of the overall float, the days-to-cover ratio (short ratio) decline to 5.

Which companies own the most shares of Exact Sciences Corporation (EXAS)?

According to The Vanguard Group, Inc. filings, the company currently owns 15,619,924 shares, which is about 8.83% of the total EXAS shares outstanding. The investor’s shares have appreciated by 333,626 from its previous 13-F filing of 15286298.0 shares. With the completion of the sale transaction, T. Rowe Price Associates, Inc.’s stake is now worth $548,265,751. ARK Investment Management LLC acquire a 4.52% interest valued at $532.25 million while Wellington Management Co. LLP sold a -2,463,167 stake. A total of -133,307 shares of Exact Sciences Corporation were sold by BlackRock Fund Advisors during the quarter, and 405,369 were bought by Capital Research & Management Co. In its current portfolio, Nikko Asset Management Co., Ltd. holds 5,807,605 shares valued at $206.46 million.

In terms of Exact Sciences Corporation share price expectations, FactSet research, analysts set an average price target of $70.06 in the next 12 months, up nearly 84.75% from the previous closing price of $37.89. Analysts anticipate Exact Sciences Corporation stock to reach $110.00 by 2022, with the lowest price target being $40.00. In spite of this, 20 analysts ranked Exact Sciences Corporation stock as a Buy at the end of 2022. On July 29, 2021, Oppenheimer assigned a price target of “an Outperform” to the stock and reiterated coverage with a $155.


Please enter your comment!
Please enter your name here